ArticleFrontiers in oncology2026

Longitudinal evaluation of health-related quality of life in Chinese patients with early-stage HER2-positive breast cancer undergoing neratinib extended adjuvant therapy: a real-world prospective cohort study.

Xuanhua Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.